Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study
- PMID: 26087071
- PMCID: PMC4665735
- DOI: 10.1378/chest.15-0630
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study
Abstract
Background: Pulmonary nodules (PNs) are a common reason for referral to pulmonologists. The majority of data for the evaluation and management of PNs is derived from studies performed in academic medical centers. Little is known about the prevalence and diagnosis of PNs, the use of diagnostic testing, or the management of PNs by community pulmonologists.
Methods: This multicenter observational record review evaluated 377 patients aged 40 to 89 years referred to 18 geographically diverse community pulmonary practices for intermediate PNs (8-20 mm). Study measures included the prevalence of malignancy, procedure/test use, and nodule pretest probability of malignancy as calculated by two previously validated models. The relationship between calculated pretest probability and management decisions was evaluated.
Results: The prevalence of malignancy was 25% (n = 94). Nearly one-half of the patients (46%, n = 175) had surveillance alone. Biopsy was performed on 125 patients (33.2%). A total of 77 patients (20.4%) underwent surgery, of whom 35% (n = 27) had benign disease. PET scan was used in 141 patients (37%). The false-positive rate for PET scan was 39% (95% CI, 27.1%-52.1%). Pretest probability of malignancy calculations showed that 9.5% (n = 36) were at a low risk, 79.6% (n = 300) were at a moderate risk, and 10.8% (n = 41) were at a high risk of malignancy. The rate of surgical resection was similar among the three groups (17%, 21%, 17%, respectively; P = .69).
Conclusions: A substantial fraction of intermediate-sized nodules referred to pulmonologists ultimately prove to be lung cancer. Despite advances in imaging and nonsurgical biopsy techniques, invasive sampling of low-risk nodules and surgical resection of benign nodules remain common, suggesting a lack of adherence to guidelines for the management of PNs.
Figures
Similar articles
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation.Chest. 2017 Aug;152(2):263-270. doi: 10.1016/j.chest.2017.01.018. Epub 2017 Jan 20. Chest. 2017. PMID: 28115167 Free PMC article.
-
Indeterminate lung nodules in cancer patients: pretest probability of malignancy and the role of 18F-FDG PET/CT.AJR Am J Roentgenol. 2014 Mar;202(3):507-14. doi: 10.2214/AJR.13.11728. AJR Am J Roentgenol. 2014. PMID: 24555586
-
Risk of malignancy in pulmonary nodules: A validation study of four prediction models.Lung Cancer. 2015 Jul;89(1):27-30. doi: 10.1016/j.lungcan.2015.03.018. Epub 2015 Mar 28. Lung Cancer. 2015. PMID: 25864782
-
Evaluating the Patient With a Pulmonary Nodule: A Review.JAMA. 2022 Jan 18;327(3):264-273. doi: 10.1001/jama.2021.24287. JAMA. 2022. PMID: 35040882 Review.
-
PET scanning and the solitary pulmonary nodule.Semin Thorac Cardiovasc Surg. 2002 Jul;14(3):268-74. doi: 10.1053/stcs.2002.33429. Semin Thorac Cardiovasc Surg. 2002. PMID: 12232868 Review.
Cited by
-
Vascular Biomarkers for Pulmonary Nodule Malignancy: Arteries vs. Veins.Cancers (Basel). 2024 Sep 26;16(19):3274. doi: 10.3390/cancers16193274. Cancers (Basel). 2024. PMID: 39409894 Free PMC article.
-
Assessing the transportability of radiomic models for lung cancer diagnosis: commercial vs. open-source feature extractors.Transl Lung Cancer Res. 2024 Aug 31;13(8):1907-1917. doi: 10.21037/tlcr-24-281. Epub 2024 Aug 26. Transl Lung Cancer Res. 2024. PMID: 39263016 Free PMC article.
-
Exploring the Diagnostic Dilemma of Indeterminate Pulmonary Nodules in Patients with Primary Sarcoma of Bone.Sarcoma. 2024 Mar 5;2024:9926675. doi: 10.1155/2024/9926675. eCollection 2024. Sarcoma. 2024. PMID: 38476458 Free PMC article.
-
Radiomics and artificial intelligence for risk stratification of pulmonary nodules: Ready for primetime?Cancer Biomark. 2024 Feb 6:10.3233/CBM-230360. doi: 10.3233/CBM-230360. Online ahead of print. Cancer Biomark. 2024. PMID: 38427470
-
Assessing the clinical utility of biomarkers using the intervention probability curve (IPC).Cancer Biomark. 2023 Oct 28:10.3233/CBM-230054. doi: 10.3233/CBM-230054. Online ahead of print. Cancer Biomark. 2023. PMID: 38073376
References
-
- Kanne JP, Jensen LE, Mohammed TL, et al. ; Expert Panel on Thoracic Imaging. ACR appropriateness Criteria® radiographically detected solitary pulmonary nodule. J Thorac Imaging. 2013;28(1):W1-3. - PubMed
-
- Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348(25):2535-2542. - PubMed
-
- Lehto RH. Identifying primary concerns in patients newly diagnosed with lung cancer. Oncol Nurs Forum. 2011;38(4):440-447. - PubMed
-
- Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013;119(7):1381-1385. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
